Skip to main content

Table 2 Characteristics of patients with follow-up, who underwent 68Ga-DOTATOC-PET/MRI before PRRT and were used to assess the predictive value of 68Ga-DOTATOC-PET/MRI

From: Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

All patients (N = 28)

Age (years)

 Median (range)

66.1 (22–88)

Sex

N

 Male

17

 Female

11

Primary

N

 Pancreas

10

 Small intestine

9

 CUP

4

 Lungs

1

 Rectum

1

 Stomach

1

 Kidney

1

 Paraganglioma

1

Grading

N

 1

9

 2

14

 3

3

 Unknown

 

Treatment response

 Treatment response

23

 No response

5

Nuclide

177Lutetium

15

90Yttrium

13

NETTER-1 protocol

 

 yes

3

 no

25

Cycles before follow-up

 1

24

 2

1

 4

3

Therapeutic Activity

 Mean (range)

7.92 (4–30.2)